minimum duration required between premedicating agents and inducing agents to decrease the dose required for inducing agent and to maintain better vital parameters

Optimum duration between premedication and induction for reducing dose of induction agent as well as maintaining better hemodynamics

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/08/009313

Enrollment

Registered

2017-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Posted for surgery under general anaesthesia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients belonging to American Society of Anesthesiologists physical status I & II 2. Patients undergoing neuro-surgery 3. Age group between 15 and 50 years 4. Haemodynamically stable

Exclusion criteria

Exclusion criteria: 1. History of hypertension, diabetes or other systemic illness 2. History of drug or alcohol abuse 3. History of neurological disease 4. History of chronic use of opioid, antipsychotic, antidepressant, anxiolytic drug.

Design outcomes

Primary

Measure	Time frame
Reduction in dose of propofolTimepoint: 10 minutes	—

Secondary

Measure	Time frame
Maintainance of hemodynamic parametersTimepoint: 10 minutes	—

Countries

India

Contacts

Public ContactDr Sandeep Loha

IMS, BHU, varanasi

drsandeepscb@gmail.com8960919866

Outcome results